Requirements

All of it, in the shape the answers of 17/09/2026 gave it. The expert a pharma user meets is an anonymous card carrying profession, country and topic, and no name, no employer and no question text (OQ-05). A contact request is recorded, passed to the expert, and the identity is revealed only on acceptance, with the acceptance stored as a consent record naming the company and the wording shown (OQ-42). The link between a card and a person stays inside the signal layer, which no service outside it may read. 'Sustained and specific enquiry' is the topic score of OQ-06, built from the number, recency and specificity of questions, with the top 1.4 percent of a disease area flagged until the validation study replaces the cut-off (NP-15). Research Workspace questions feed anonymous trends only, and reach a named card solely for an academic who switched on 'contactable by pharma' (OQ-07, NP-03, FD-02). The 12 researchers of the August 2026 note are excluded from every list, card and profile (OQ-33). The negative-publication verification this build already had is unchanged and is what evidences the claim.

Still held. Nothing is held by a question. One operational bound stands and is not a gate: OncoSkepsis signals are shown only once a third hospital joins (NP-01, OQ-40), so a view with nothing releasable says so, naming the minimum, rather than showing an empty result.

Released by OQ-05, OQ-06, OQ-07, OQ-33, OQ-42, NP-03, NP-15, FD-02.

All of it. Every input it needed is now stated. The accelerating designation reads the OQ-06 topic score rather than a raw question count, so 'asked more and more often' is a movement in that score. A trend is shown only when at least 8 different people stand behind it, and every displayed count is rounded to the nearest 5 (OQ-14). Time is the ISO week of a question and nothing finer (OQ-43). Topics are coded with OncoTree, HGNC, HGVS with ClinGen Allele Registry IDs, and ChEMBL, with the code list version stored on every signal (OQ-44). Research Workspace questions feed these aggregates and never a named expert (OQ-07).

Still held. Nothing. Two bounds travel with it rather than holding it: the 8-person minimum and the rounding apply in every view, export, alert and API answer, not only on screen, and the differencing check of NP-10 refuses an export or an API answer whose comparison could reveal a count the minimum was meant to hide.

Released by OQ-06, OQ-07, OQ-14, OQ-43, OQ-44, NP-10.

All of it. Research Workspace questions feed anonymous group trends and nothing else, under a clear privacy notice with an opt-out shown inside the Research Workspace itself (OQ-07). Every signal is tagged with the surface that produced it, and a signal tagged Research Workspace may enter trend aggregates only. An academic who switches on 'contactable by pharma' may receive a contact request, and even then appears exactly as a clinician does: an anonymous card until they accept (NP-03, FD-02).

Still held. Nothing in this build. One dependency sits outside it: the notice and the opt-out control live in the Research Workspace, and the lawful basis is a legitimate interest whose balancing test the external data protection officer confirms (OQ-36).

Released by OQ-07, NP-03, FD-02.